CORSINI, GIOVANNI UMBERTO
 Distribuzione geografica
Continente #
NA - Nord America 13.198
EU - Europa 9.346
AS - Asia 1.491
AF - Africa 105
SA - Sud America 18
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 24.170
Nazione #
US - Stati Uniti d'America 10.594
PL - Polonia 4.296
CA - Canada 2.597
IT - Italia 1.449
SE - Svezia 1.000
CN - Cina 866
GB - Regno Unito 683
BG - Bulgaria 494
UA - Ucraina 446
DE - Germania 358
FI - Finlandia 260
TR - Turchia 229
VN - Vietnam 218
CH - Svizzera 160
CI - Costa d'Avorio 78
RU - Federazione Russa 63
SG - Singapore 59
FR - Francia 51
IN - India 47
HK - Hong Kong 46
BE - Belgio 30
SN - Senegal 21
GR - Grecia 12
BR - Brasile 9
ES - Italia 8
KR - Corea 8
NL - Olanda 8
CZ - Repubblica Ceca 7
NZ - Nuova Zelanda 6
HU - Ungheria 5
JP - Giappone 5
MX - Messico 5
IE - Irlanda 4
NG - Nigeria 4
AR - Argentina 3
AU - Australia 3
CO - Colombia 3
EE - Estonia 3
EU - Europa 3
AE - Emirati Arabi Uniti 2
CR - Costa Rica 2
HR - Croazia 2
IL - Israele 2
PE - Perù 2
PH - Filippine 2
RO - Romania 2
ZA - Sudafrica 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AT - Austria 1
BD - Bangladesh 1
CL - Cile 1
ID - Indonesia 1
IS - Islanda 1
LU - Lussemburgo 1
MD - Moldavia 1
MY - Malesia 1
PK - Pakistan 1
SA - Arabia Saudita 1
TW - Taiwan 1
Totale 24.170
Città #
Montreal 2.299
Woodbridge 1.390
Fairfield 1.177
Ann Arbor 1.081
Houston 1.005
Chandler 947
Ashburn 618
Jacksonville 588
Milan 544
Seattle 531
Sofia 494
Cambridge 418
Wilmington 409
Lancaster 388
Beijing 339
Ottawa 285
New York 280
Izmir 227
Nanjing 196
Princeton 193
Lawrence 187
Medford 172
Bern 157
Des Moines 130
Serra 130
Dearborn 128
Jüchen 100
Nanchang 91
Dong Ket 88
London 87
Abidjan 78
San Diego 56
Hong Kong 46
Redwood City 45
Kunming 41
Boulder 40
Rome 40
Ogden 31
Brussels 30
Los Angeles 30
Norwalk 30
Florence 29
Frankfurt am Main 27
Pune 27
Shenyang 27
Bremen 26
Hebei 25
Changsha 24
Falls Church 22
Dakar 21
Verona 21
Düsseldorf 20
Tianjin 20
Jiaxing 18
Orange 18
Boardman 14
Washington 14
Grafing 13
Hefei 13
Auburn Hills 11
Chicago 10
Lanzhou 10
Marseille 10
Pisa 10
Detroit 9
Guangzhou 8
Phoenix 8
Changchun 7
Madrid 7
Prague 7
San Francisco 6
Chengdu 5
Council Bluffs 5
Hanoi 5
Indiana 5
São Paulo 5
Walnut 5
Zhengzhou 5
Budapest 4
Dallas 4
Edinburgh 4
Hangzhou 4
Helsinki 4
Jinan 4
Lagos 4
Mumbai 4
Ningbo 4
San Giovanni Suèrgiu 4
Tappahannock 4
Auckland 3
Baotou 3
Boston 3
Cali 3
Capannori 3
Kilburn 3
Kolkata 3
Leawood 3
New Bedfont 3
North York 3
Palermo 3
Totale 15.740
Nome #
Parkinsonism by MPTP in mice: a model for regenerative processes of nigrostriatal dopaminergic pathway 3.378
MPTP FAILS TO INDUCE LIPID-PEROXIDATION INVIVO 2.023
PARKINSONS-DISEASE AND PESTICIDES 1.123
HIGH-AFFINITY BINDING-SITES FOR 1-METHYL-4-PHENYL-PYRIDINIUM ION (MPP+) ARE PRESENT IN MOUSE-BRAIN 468
Pharmacological manipulation of embryonic dopaminergic neurons implanted in adult mouse striatum: a new therapeutical approach to Parkinson’s disease. 167
Characterization of the Engrailed mutant mice as experimental models for Parkinson's disease 155
Involvement of cytochrome P450 2E1 in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease 152
Region- and neurotransmitter-dependent species and strain differences in DSP-4-induced monoamine depletion in rodents. 152
Localization of a glutathione-dependent dehydroascorbate reductase within the central nervous system of the rat 149
[H-3] 1-METHYL-4-PHENYL-2,3-DIHYDROPYRIDINIUM ION BINDING-SITES IN MOUSE-BRAIN - PHARMACOLOGICAL AND BIOLOGICAL CHARACTERIZATION 144
Partial agonist actions of aripiprazole and the candidate antipsychotics S33592, bifeprunox, N-desmethylclozapine and preclamol at dopamine D(2L) receptors are modified by co-transfection of D(3) receptors: potential role of heterodimer formation 143
Ethanol intake and ethanol-induced locomotion and locomotor sensitization in CYP2E1 knockout mice 142
TSH-Dependent Expression of the LDL Receptor-Associated Protein (RAP) in Thyroid Epithelial Cells 140
Embryonic neural grafts induce recovery in mice with permanent striatal lesion 138
Assessing neuroprotection in Parkinson's disease: from the animal models to molecular neuroimaging in vivo 137
G protein-linked receptors: pharmacological evidence for the formation of heterodimers 136
Effects of Pretreatment with N-(2-Chloroethyl)-N- Ethyl-2-Bromobenzylamine (DSP-4) of Methamphetamine Pharmacokinetics and Striatal Dopamine losses 136
INCREASED PAROXYSMAL ACTIVITY OF PARTIAL SEIZURES IN MAN BY APOMORPHINE 132
Partial agonist actions at dopamine D2L receptors are modified by co-transfection of D3 receptors: potential role of heterodimer formation 132
Effect of metadoxine on striatal dopamine levels in C57 black mice 132
Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors. 132
Modulation of dihydroxyphenylacetaldehyde extracellular levels in vivo in the rat striatum after different kinds of pharmacological treatment 131
Clozapine as the most efficacious antipsychotic for activating ERK 1/2 kinases: Role of 5-HT2A receptor agonism 130
1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE - CORRESPONDENCE OF ITS BINDING-SITES TO MONOAMINE-OXIDASE IN RAT-BRAIN, AND INHIBITION OF DOPAMINE OXIDATIVE DEAMINATION INVIVO AND INVITRO 129
Pharmacologic modulation of MPTP toxicity: MK 801 in prevention of dopaminergic cell death in monkeys and mice. 128
Apomorphine offers new insight into dopaminergic neuron vulnerability in mesencephalic cultures 127
Identification and determination of 3,4-dihydroxyphenylacetaldehyde, the dopamine metabolite in in vivo dialysate from rat striatum. 126
Apomorphine has a potent antiproliferative effect on Chinese hamster ovary cells 126
Pharmacological modulation of regenerative processes aftar nigrostriatal dopaminergic lesion: a new therapeutical approach to Parkinson’s disease 125
HIGH-AFFINITY BINDING OF [H-1]1-METHYL-4-PHENYL-2,3-DIHYDROPYRIDINIUM ION TO MOUSE STRIATAL MEMBRANES - PUTATIVE VESICULAR LOCATION 125
MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates. 125
Fluorescent light induces neurodegeneration in the rodent nigrostriatal system but near infrared LED light does not 125
D-1 AND D-2 DOPAMINE SYSTEM INTERACTIONS IN THE MPTP-LESIONED MONKEY 123
Pharmacological modulation of regenerative processes after nigrostriatal dopaminergic lesion: A new therapeutical approach to Parkinson's disease 123
From dopamine metabolism to Parkinson’s disease. 121
(+)MK-801 PREVENTS THE DDC-INDUCED ENHANCEMENT OF MPTP TOXICITY IN MICE 121
CYP 2E1 mutant mice are resistant to DDC-induced enhancement of MPTP toxicity 121
DEPRENYL SELECTIVELY INHIBITS [H-3] MPTP BINDING-SITES IN MONKEY BRAIN 120
Species differences in the role of excitatory amino acids in experimental parkinsonism. 118
MPTP TREATMENT COMBINED WITH ETHANOL OR ACETALDEHYDE SELECTIVELY DESTROYS DOPAMINERGIC-NEURONS IN MOUSE SUBSTANTIA NIGRA 116
INHIBITION OF NITRIC-OXIDE SYNTHASE DRAMATICALLY POTENTIATES SEIZURES INDUCED BY KAINIC ACID AND PILOCARPINE IN RATS 116
Sodium nitroprusside induces internalization of muscarinic receptors stably expressed in Chinese hamster ovary cell lines 116
EVIDENCE FOR DOPAMINE RECEPTORS IN HUMAN-BRAIN MEDIATING SEDATION AND SLEEP 115
Behavioral, Neurochemical, and Electrophysiological Changes in an Early Spontaneous Mouse Model of Nigrostriatal Degeneration 115
Acetaldehyde and parkinsonism: role of CYP450 2E1. 115
Clonidine prevents while yohimbine enhances MPTP toxicity in mice. 114
Functional role of the third cytoplasmic loop in muscarinic receptor dimerization. 114
Dose-dependent induction of apoptosis by R-apomorphine in CHO-K 1 cell line in culture 114
Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease epidemiology. 114
An unusual form of the association binding kinetics of N-[ [H-3] methylscopolamine to the split muscarinic M-2trunk/M-2tail receptor 113
Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism. 113
Serotonin abnormalities in engrailed-2 knockout mice: new insight relevant for a model of autism spectrum disorder 112
Role of CYP2E1 in the mouse model of MPTP toxicity 111
COVALENT BINDING AS A BIOCHEMICAL MECHANISM FOR TOXICITIES COVALENT BINDING OF STILBENE (ST) AND DIETHYLSTILBESTROL (DES) TO LIVER-MICROSOMES 110
Cytochrome P450 and Parkinson's disease: protective role of neuronal CYP 2E1 from MPTP toxicity 109
ACETALDEHYDE DIRECTLY ENHANCES MPP+ NEUROTOXICITY AND DELAYS ITS ELIMINATION FROM THE STRIATUM 108
PHARMACOLOGICAL MODULATION OF DEVELOPMENT AND PLASTICITY IN NIGRO-STRIATAL DOPAMINERGIC-NEURONS 108
SELECTIVE INCREASE OF BRAIN DOPAMINE SYNTHESIS BY SULPIRIDE 106
CHARACTERIZATION OF A PUTATIVELY VESICULAR BINDING-SITE FOR [H-3] MPP+ IN MOUSE STRIATAL MEMBRANES 106
EFFECTS OF BIGUANIDES ON FATTY-ACID AND GLUCOSE OXIDATION IN MUSCLE 104
DOPAMINERGIC MECHANISMS IN HEMIPARKINSONIAN MONKEYS 104
EFFECT OF APOMORPHINE ON HUMAN SLEEP 103
PROPERTIES OF BENZODIAZEPINE BINDING-SITES IN PERIPHERAL-TISSUES 103
Norepinephrine loss exacerbates methamphetamine-induced striatal dopamine depletion in mice 103
1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) NEUROTOXICITY IN MICE IS ENHANCED BY PRETREATMENT WITH DIETHYLDITHIOCARBAMATE 103
INHIBITION OF [H-3] MPTP BINDING TO RAT-BRAIN BY PARGYLINE 102
MODULATION OF DOPAMINE AGONIST ACTION BY ESTROGENS 101
Is lithium able to reverse neurological damage induced by vinca alkaloids? 101
Apomorphine, dopamine and phenylethylamine reduce the proportion of phosphorylated insulin receptor substrate 1 101
Norepinephrine loss selectively enhances chronic nigrostriatal dopamine depletion in mice and rats 101
APOMORPHINE HYDROCHLORIDE-INDUCED IMPROVEMENT IN HUNTINGTONS-CHOREA - STIMULATION OF DOPAMINE RECEPTOR 100
EFFECT OF ORAL-ADMINISTRATION OF TRYPTOPHAN-FREE AMINO-ACID MIXTURES ON SERUM TRYPTOPHAN, BRAIN TRYPTOPHAN AND SEROTONIN METABOLISM 100
PHARMACOLOGICAL MANIPULATION OF EMBRYONIC DOPAMINERGIC-NEURONS IMPLANTED IN ADULT-MOUSE STRIATUM - A NEW THERAPEUTIC APPROACH TO PARKINSONS-DISEASE 100
Antagonist binding profile of the split chimeric muscarinic m2-trunc/m3-tail receptor 100
THERAPEUTIC EFFICACY OF APOMORPHINE COMBINED WITH AN EXTRA-CEREBRAL INHIBITOR OF DOPAMINE RECEPTORS IN PARKINSONS-DISEASE 99
Biochemestry of experimental parkinsonism. 99
METOCLOPRAMIDE AND DYSTONIC REACTIONS IN SARDINIANS 99
L-deprenyl fails to protect mesencephalic dopamine neurons and PC12 cells from the neurotoxic effect of 1-methyl-4-phenylpyridinium ion 99
Increased susceptibility to kainic acid-induced seizures in Engrailed-2 knockout mice. 99
SPECIFIC REINNERVATION OF LESIONED MOUSE STRIATUM BY GRAFTED MESENCEPHALIC DOPAMINERGIC-NEURONS 98
Noradrenergic modulation of methamphetamine-induced striatal dopamine depletion 98
Revealing G-protein-coupled receptor oligomerization at the single-molecule level through a nanoscopic lens: Methods, dynamics and biological function 98
(+) MK-801 PREVENTS DIETHYLDITHIOCARBAMATE-INDUCED NEURONAL DAMAGE 97
Molecular and cellular events regulating dopamine survival 97
Dextromethorphan prevents the diethyldithiocarbamate enhancement of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice 97
IN BROWN-NORWAY RATS, MPP(+) IS ACCUMULATED IN THE NIGROSTRIATAL DOPAMINERGIC TERMINALS BUT IT IS NOT NEUROTOXIC - A MODEL OF NATURAL-RESISTANCE TO MPTP TOXICITY 96
Nicotine prevents experimental parkinsonism in rodents. 96
PARKINSONISM BY HALOPERIDOL AND PIRIBEDIL 95
DOMPERIDONE AND APOMORPHINE IN HUNTINGTONS-CHOREA 95
ROLE OF H-3 MPP+ BINDING-SITES IN THE MPTP NEUROTOXICITY USING QUANTITATIVE AUTORADIOGRAPHY 95
Excitatory amino acids and MPTP toxicity 95
Apomorphine test for dopaminergic responsiveness: a dose assessment study 95
DECREASED CONVERSION OF TYROSINE TO CATECHOLAMINES IN BRAIN OF RATS TREATED WITH PARA CHLOROPHENYLALANINE 94
DOPAMINE AGONISTS IN THE TREATMENT OF SCHIZOPHRENIA 94
1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE (MPTP) NEUROTOXICITY IN MICE IS ENHANCED BY ETHANOL OR ACETALDEHYDE 94
INCREASE OF BRAIN HOMOVANILLIC-ACID LEVEL INDUCED BY METOCLOPRAMIDE 94
DEMONSTRATION OF MECHANISM OF ACTION OF BIGUANIDES 93
EVALUATION OF THE TOXICITY OF THE DOPAMINERGIC NEUROTOXINS MPTP AND MPP+ IN PC12 PHEOCHROMOCYTOMA CELLS - BINDING AND BIOLOGICAL STUDIES 93
Pergolide binds tightly to dopamine D2 short receptors and induces receptor sequestration 93
ETIOLOGY OF PARKINSONS-DISEASE 92
Totale 17.920
Categoria #
all - tutte 47.640
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 47.640


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019859 0 0 0 0 0 0 0 0 0 0 494 365
2019/20203.247 381 290 128 219 359 370 384 234 359 183 294 46
2020/20211.760 180 78 187 125 189 72 127 155 141 140 102 264
2021/20222.059 66 106 41 155 413 269 32 96 102 73 86 620
2022/20232.469 355 354 124 241 274 359 27 184 389 12 125 25
2023/20248.495 386 212 335 124 267 369 42 74 42 6.644 0 0
Totale 24.401